136 related articles for article (PubMed ID: 51002)
1. Evidence for a membrane carrier molecule common to embryonal and tumour-specific antigenic determinants expressed by a mouse transplantable tumour.
Comoglio PM; Bertini M; Forni G
Immunology; 1975 Aug; 29(2):353-64. PubMed ID: 51002
[TBL] [Abstract][Full Text] [Related]
2. Hypertonic salt solution of superficial membrane proteins from ATPc+ mouse ascites tumour which retain tumour specific antigenic properties.
Pitzurra M; Marconi P; Bistoni F
Boll Ist Sieroter Milan; 1973; 52(4):346-8. PubMed ID: 4130350
[No Abstract] [Full Text] [Related]
3. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
4. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
5. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis.
Bertini M; Forni G; Comoglio PM
Clin Exp Immunol; 1974 Sep; 18(1):101-8. PubMed ID: 4468189
[TBL] [Abstract][Full Text] [Related]
6. Immunological analysis of A strain mice bearing the A-10 mammary adenocarcinoma.
Tax A; Manson LA
Cancer Res; 1979 May; 39(5):1739-47. PubMed ID: 85488
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of membrane-associated determinants is an outgrowth of their metabolism.
Cohen EP
Prog Clin Biol Res; 1980; 42():145-68. PubMed ID: 6248890
[TBL] [Abstract][Full Text] [Related]
8. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
[TBL] [Abstract][Full Text] [Related]
9. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
10. Lack of Thy 1.2 antigen expression on the surfaces of mouse mammary epithelial cells.
Thompson K
J Natl Cancer Inst; 1981 Jul; 67(1):143-8. PubMed ID: 6265679
[TBL] [Abstract][Full Text] [Related]
11. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
12. The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice.
Vyakarnam A; Lachmann PJ; Sikora K
Immunology; 1981 Feb; 42(2):337-48. PubMed ID: 6161889
[TBL] [Abstract][Full Text] [Related]
13. [Cross-reacting epithelial antigen of ectodermal origin in mouse tumors].
Beletskaia LV; Gnezditskaia EV; Raĭkhlin NT; Borodniuk NA; Rassokhina II
Vopr Onkol; 1977; 23(10):83-7. PubMed ID: 74128
[TBL] [Abstract][Full Text] [Related]
14. Class 1 (unique) tumor antigens of human melanoma: partial purification and characterization of the FD antigen and analysis of a mouse polyclonal antiserum.
Mattes MJ; Real FX; Furukawa K; Old LJ; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6614-9. PubMed ID: 2445475
[TBL] [Abstract][Full Text] [Related]
15. Expression of a T cell receptor-like molecule on normal and malignant murine T cells detected by rat monoclonal antibodies to nonclonotypic determinants.
Chan PY; Takei F
J Immunol; 1986 Feb; 136(4):1346-53. PubMed ID: 2418112
[TBL] [Abstract][Full Text] [Related]
16. Tumour specific and embryonic antigen expression of chemically induced rat tumours.
Baldwin RW; Glaves D; Pimm MV; Vose BM
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):715-28. PubMed ID: 4340543
[No Abstract] [Full Text] [Related]
17. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
Ohnishi K; Bonavida B
J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of murine plasmocytoma tumours with antibody activity by their respective specific antigens.
Paraf A; Guérin-Marchand C; Aubry J; Dubert JM
Ann Immunol (Paris); 1975; 126C(4):411-21. PubMed ID: 55094
[TBL] [Abstract][Full Text] [Related]
19. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
DeLustro F; Haskill JS
J Natl Cancer Inst; 1980 Jan; 64(1):125-30. PubMed ID: 6928037
[TBL] [Abstract][Full Text] [Related]
20. [Growth control of experimental tumour. I. Host protection against tumour by previous inoculation of plasmatic membrane of tumour cell (author's transl)].
Gomes RM; Preza PA; Bastos VC; Coelho MG; Kovary K; de Castro Faria H
Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):229-35. PubMed ID: 725135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
